The Agency for Healthcare Research ...

The Agency for Healthcare Research and Quality has issued a systematic review of the evidence regarding screening patients for celiac disease, a small-bowel malabsorption disorder that be deriveds in mucosal inflammation, villous atrophy, and vault hyperplasia, which occur on exposing to gluten, and clinical and histologic improvement when gluten is withdrawn from the diet. The glutted report is available at http://www.ahrq.gov/ downloads/pub/evidence/pdf/celiac/celiac. pdf; a shorter summary is available at http:// www.ahrq.gov/clinic/epcsums/celiacsum. htm While the report does not make specific recommendations, it provides the best available evidence thus physicians and patients can make their possess decisions.

Celiac disease--also referr to as celiac sprue gluten-sensitive enteropathy, and non-tropical sprue--is consideration to result from the activation of the one and the other a cell-mediated (T cell) and humoral (B cell) immune answer on exposure to the gluten (prolamins and glutenins) of wheat, barley, rye and oats in a genetically susceptible one The diagnosis of celiac disease in adults is classically made in succession the basis of clinical suspicion (i.e., isolated iron deficiency, combined iron and folate deficiency, osteoporosis) and findings of a duodenal biopsy while the patient is in succession a gluten-containing diet, followed by means of clinical and histologic improvement after a gluten-free diet (GFD) is initiated.

Untreated celiac disease is associated with a number of complications, including nutritional riddles anemia, reduced bone-mineral density, and intestinal lymphoma. greatest in number patients are treated successfully with a GFD However, mounting evidence implies that celiac disease is frequently more common than previously was speculation so patients at risk should be screened

In this report, investigators assessed the literature to systematically review five areas of celiac disease: (1) sensitivity and specificity of serologic tests; (2) prevalence and incidence of celiac disease; (3) celiac disease-associated lymphoma; (4) connections of testing for celiac disease; and (5) interventions to institute a GFD

Sensitivity and Specificity of Serologic Tests

Several serologic markers have become available that may help diagnose celiac disease. The sensitivity of IgA anti-gliadin antibodies is reported to range from 70 to 85 percent; the specificity ranges from 70 to 90 percent IgA anti-endomysial and anti-tissue trans-glutaminase antibodies have sensitivities that exce 90 percent and specificities of more than 95 percent

Human leukocyte antigen DQ2/DQ8 testing also may be useful in diagnosing celiac disease. The trial has high sensitivity (exceeding 90 to 95 percent) moreover because about 30 percent of the general population, and an calm higher proportion of high-risk bodys (e.g., those with diabetes), also carry these markers, the specificity of this experiment is not ideal. The best use of this criterion is its negative predictive value. That is, when negative, it behaviors out the diagnosis, but when positive, it requires confirmation.

Biopsy itself, when used with a strict cutoff requiring villous atrophy, appears to have high specificity still poor sensitivity. Thus, it is helpful at confirming a suspected diagnosis when positive, if it were not that a negative result does not authority out the diagnosis. The use of a lower-grade cutoff improves sensitivity, if it be not that then the specificity suffers. The use of histo-morphometric measures as it is as quantification of gamma delta positive intraepithelial lymphocyte is likely to allow for the use of lower-grade cutoffs while maintaining reasonable specificity.

Prevalence and Incidence of Celiac Disease

The prevalence of celiac disease is hard to estimate because of the variable presentation of the disease and because many patients do not exhibit symptoms. However, the disease arises most often in Celtic populations. Celiac disease can affect bodily forms of various ethnic backgrounds, if it were not that it rarely affects persons of totally Chinese, Japanese, or Afro-Caribbean going down Several high-risk groups who have a prevalence of celiac disease greater than that of the general population have been identified and include first-degree family members of patients with celiac disease, and parts with type 1 diabetes, iron-deficiency anemia, reasonable bone-mineral density (i.e., osteoporosis, osteopenia), Down syndrome short stature, or infertility.

The unrefined incidence of celiac disease in adults varied from depresseds of 1.3 per 100,000 patient-years in Denmark and 31 by 100,000 patient-years in England to a high of 172 cases by 100,000 patient-years in Finland, where specific efforts had been undertaken to encourage screening for celiac disease.

The prevalence studies that were reviewed had important differences, including execution, experiments for prevalence assessment, and patient sampling. Thus, consequence s have to be interpreted in light of a of the limitations of the testing for celiac disease. Nonetheless, the data prompt that celiac disease is a often met with disorder, with a prevalence in the general population that is likely stop to 1:100 (1 percent).